144 related articles for article (PubMed ID: 36894815)
1. Dynamics of Changes in the Properties of Multipotent Mesenchymal Stromal Cells in Patients with Acute Leukemia.
Sadovskaya AV; Petinati NA; Kapranov NM; Drize NI; Vasil'eva AN; Aleshina OA; Parovichnikova EN
Bull Exp Biol Med; 2023 Feb; 174(4):556-563. PubMed ID: 36894815
[TBL] [Abstract][Full Text] [Related]
2. Changes in Bone Marrow Stromal Progenitor Cells in Patients with Hematoblastosis at the Onset of the Disease.
Petinati NA; Shipounova IN; Fastova EA; Magomedova AU; Kravchenko SK; Chelysheva EY; Shukhov OA; Turkina AG; Sats NV; Drize NI; Parovichnikova EN; Savchenko VG
Bull Exp Biol Med; 2021 Aug; 171(4):553-558. PubMed ID: 34542753
[TBL] [Abstract][Full Text] [Related]
3. Acute Myeloid Leukemia Causes Serious and Partially Irreversible Changes in Secretomes of Bone Marrow Multipotent Mesenchymal Stromal Cells.
Sadovskaya A; Petinati N; Drize N; Smirnov I; Pobeguts O; Arapidi G; Lagarkova M; Belyavsky A; Vasilieva A; Aleshina O; Parovichnikova E
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240298
[TBL] [Abstract][Full Text] [Related]
4. Biogenesis of Mitochondria in Multipotent Mesenchymal Stromal Cells in Patients with Acute Leukemia.
Sadovskaya AV; Petinati NA; Sats NV; Drize NI; Vasil'eva AN; Aleshina OA; Parovichnikova EN
Bull Exp Biol Med; 2023 Dec; 176(2):283-289. PubMed ID: 38194072
[TBL] [Abstract][Full Text] [Related]
5. Alterations in multipotent mesenchymal stromal cells from the bone marrow of acute myeloid leukemia patients at diagnosis and during treatment.
Shipounova IN; Petinati NA; Bigildeev AE; Sorokina TV; Kuzmina LA; Parovichnikova EN; Savchenko VG
Leuk Lymphoma; 2019 Aug; 60(8):2042-2049. PubMed ID: 30668205
[TBL] [Abstract][Full Text] [Related]
6. Bone Marrow Multipotent Mesenchymal Stromal Cells from Patients with Aplastic Anemia Retain Their Ability to Support Hematopoietic Precursors despite Pronounced Changes in Gene Expression.
Dorofeeva AI; Shipunova IN; Drize NI; Luchkin AV; Abramova AV; Fidarova ZT; Dvirnyk VN; Gal'tseva IV; Mikhailova EA; Parovichnikova EN
Bull Exp Biol Med; 2022 Mar; 172(5):637-641. PubMed ID: 35352257
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.
Geyh S; Rodríguez-Paredes M; Jäger P; Koch A; Bormann F; Gutekunst J; Zilkens C; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
Haematologica; 2018 Sep; 103(9):1462-1471. PubMed ID: 29773599
[TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
[TBL] [Abstract][Full Text] [Related]
9. Molecular Changes in Immunological Characteristics of Bone Marrow Multipotent Mesenchymal Stromal Cells in Lymphoid Neoplasia.
Petinati NA; Sadovskaya AV; Sats NV; Kapranov NM; Davydova YO; Fastova EA; Magomedova AU; Vasilyeva AN; Aleshina OA; Arapidi GP; Shender VO; Smirnov IP; Pobeguts OV; Lagarkova MA; Drize NI; Parovichnikova EN
Biochemistry (Mosc); 2024 May; 89(5):883-903. PubMed ID: 38880649
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors.
Chandran P; Le Y; Li Y; Sabloff M; Mehic J; Rosu-Myles M; Allan DS
Leuk Res; 2015 Apr; 39(4):486-93. PubMed ID: 25703353
[TBL] [Abstract][Full Text] [Related]
11. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
[TBL] [Abstract][Full Text] [Related]
12. Alterations of the bone marrow stromal microenvironment in adult patients with acute myeloid and lymphoblastic leukemias before and after allogeneic hematopoietic stem cell transplantation.
Shipounova IN; Petinati NA; Bigildeev AE; Drize NJ; Sorokina TV; Kuzmina LA; Parovichnikova EN; Savchenko VG
Leuk Lymphoma; 2017 Feb; 58(2):408-417. PubMed ID: 27244369
[TBL] [Abstract][Full Text] [Related]
13. The ability of multipotent mesenchymal stromal cells from the bone marrow of patients with leukemia to maintain normal hematopoietic progenitor cells.
Sorokina T; Shipounova I; Bigildeev A; Petinati N; Drize N; Turkina A; Chelysheva E; Shukhov O; Kuzmina L; Parovichnikova E; Savchenko V
Eur J Haematol; 2016 Sep; 97(3):245-52. PubMed ID: 26643284
[TBL] [Abstract][Full Text] [Related]
14. Adipogenic Mesenchymal Stromal Cells from Bone Marrow and Their Hematopoietic Supportive Role: Towards Understanding the Permissive Marrow Microenvironment in Acute Myeloid Leukemia.
Le Y; Fraineau S; Chandran P; Sabloff M; Brand M; Lavoie JR; Gagne R; Rosu-Myles M; Yauk CL; Richardson RB; Allan DS
Stem Cell Rev Rep; 2016 Apr; 12(2):235-44. PubMed ID: 26649729
[TBL] [Abstract][Full Text] [Related]
15. Alteration Analysis of Bone Marrow Mesenchymal Stromal Cells from De Novo Acute Myeloid Leukemia Patients at Diagnosis.
Desbourdes L; Javary J; Charbonnier T; Ishac N; Bourgeais J; Iltis A; Chomel JC; Turhan A; Guilloton F; Tarte K; Demattei MV; Ducrocq E; Rouleux-Bonnin F; Gyan E; Hérault O; Domenech J
Stem Cells Dev; 2017 May; 26(10):709-722. PubMed ID: 28394200
[TBL] [Abstract][Full Text] [Related]
16. [Effect of Acute Myeloid Leukemia Cells on the Proliferation and Apoptosis of Bone Marrow-Derived Mesenchymal Stromal Cells].
Chen ZH; Zheng YX; Si JQ; Yuan T; Zhang ZR; Tian C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):430-434. PubMed ID: 35395975
[TBL] [Abstract][Full Text] [Related]
17. De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes.
Lopes MR; Pereira JK; de Melo Campos P; Machado-Neto JA; Traina F; Saad ST; Favaro P
Sci Rep; 2017 Jan; 7():40707. PubMed ID: 28084439
[TBL] [Abstract][Full Text] [Related]
18. Distinct protein signatures of acute myeloid leukemia bone marrow-derived stromal cells are prognostic for patient survival.
Kornblau SM; Ruvolo PP; Wang RY; Battula VL; Shpall EJ; Ruvolo VR; McQueen T; Qui Y; Zeng Z; Pierce S; Jacamo R; Yoo SY; Le PM; Sun J; Hail N; Konopleva M; Andreeff M
Haematologica; 2018 May; 103(5):810-821. PubMed ID: 29545342
[TBL] [Abstract][Full Text] [Related]
19. TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
Schelker RC; Iberl S; Müller G; Hart C; Herr W; Grassinger J
Hematology; 2018 Jul; 23(6):337-345. PubMed ID: 29140182
[TBL] [Abstract][Full Text] [Related]
20. Comparison of immune modulatory properties of human multipotent mesenchymal stromal cells derived from bone marrow and placenta.
Sarıkaya A; Aydın G; Özyüncü Ö; Şahin E; Uçkan-Çetinkaya D; Aerts-Kaya F
Biotech Histochem; 2022 Feb; 97(2):79-89. PubMed ID: 33641543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
